CAS: 131069-91-5 - Gadoversetamide
Formula:C20H34GdN5O10
InChI:InChI=1S/C20H37N5O10.Gd/c1-34-9-3-21-16(26)11-24(14-19(30)31)7-5-23(13-18(28)29)6-8-25(15-20(32)33)12-17(27)22-4-10-35-2;/h3-15H2,1-2H3,(H,21,26)(H,22,27)(H,28,29)(H,30,31)(H,32,33);/q;+3/p-3
InChI key:InChIKey=HBEAOBRDTOXWRZ-UHFFFAOYSA-K
SMILES:O=C1[O-][Gd+3]234567O=C(NCCOC)C[N]7(C1)CC[N]6(CC(=O)[O-]2)CC[N]5(CC(=O)[O-]3)CC(=O4)NCCOC
- Synonyms:
- 2-Oxa-5,8,11,14-tetraazahexadecan-16-oic acid, 8,11-bis(carboxymethyl)-14-[2-[(2-methoxyethyl)amino]-2-oxoethyl]-6-oxo-, gadolinium complex
- Gadolinium, [8,11-bis[(carboxy-κO)methyl]-14-[2-[(2-methoxyethyl)amino]-2-(oxo-κO)ethyl]-6-(oxo-κO)-2-oxa-5,8,11,14-tetraazahexadecan-16-oato(3-)-κN8,κN11,κN14,κO16]-
- Gadolinium, [8,11-bis(carboxymethyl)-14-[2-[(2-methoxyethyl)amino]-2-oxoethyl]-6-oxo-2-oxa-5,8,11,14-tetraazahexadecan-16-oato(3-)]-
- [6,9-Bis[(carboxy-κO)methyl]-3-[2-[(2-methoxyethyl)amino]-2-(oxo-κO)ethyl]-11-(oxo-κO)-15-oxa-3,6,9,12-tetraazahexadecanoato(3-)-κN3,κN6,κN9,κO1]gadolinium
- Gadolinium, [6,9-bis[(carboxy-κO)methyl]-3-[2-[(2-methoxyethyl)amino]-2-(oxo-κO)ethyl]-11-(oxo-κO)-15-oxa-3,6,9,12-tetraazahexadecanoato(3-)-κN3,κN6,κN9,κO1]-
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Gadoversetamide REF: 4Z-G-186001CAS: 131069-91-5 | - - - | To inquire | Tue 25 Feb 25 | |
Gadoversetamide REF: TR-G125950CAS: 131069-91-5 | - - - | 2,320.00 € | Mon 31 Mar 25 | |
Gadoversetamide (DISCONTINUED) REF: 45-1287675CAS: 131069-91-5 | - - - | - - - | Discontinued product | |
Gadoversetamide REF: 3D-FG30026CAS: 131069-91-5 | Min. 95% | - - - | Discontinued product |
Ref: 4Z-G-186001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Gadoversetamide
Controlled ProductRef: TR-G125950
1g | 2,320.00 € |
Gadoversetamide (DISCONTINUED)
Ref: 45-1287675
200mg | Discontinued | Request information |
Gadoversetamide
Ref: 3D-FG30026
1g | Discontinued | Request information |